A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
Clinical trial NCT05102370 · COMPLETED
Trial details
- NCT number
- NCT05102370
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2026-01-26
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.